Title: 6 versus 36-month isoniazid preventive treatment – which is best?
Samandari et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377: 1588–98.
Presenter: Dr Laura Munoz, Centre for Infectious Disease Epidemiology, UCL.
Chair: Prof Ibrahim Abubakar, Centre for Infectious Disease Epidemiology, UCL.
Time: 12.00-13.00 on 20 June 2013.
Venue: Duncan Catterall room on the Lower Ground floor at the Mortimer Market Centre.
Directions: The Mortimer Market Centre is in a courtyard off Capper Street, close to Tottenham Court Road.
Isoniazid preventive treatment, is one of the 3 i’s advocated in the World Health Organisation TB/HIV strategy. Several large IPT trials have reported recently. Join us to discuss one. In light of this new evidence, should we give IPT? How long should we give IPT for? Do we need to worry about adverse events or drug resistance? The paper is available here.
North London TB Journal Club 